Minoxidil adjuvant therapies
Compositions and methods are disclosed herein for inducing (up-regulating) the expression of sulfotransferases in the hair follicles, e.g., the scalp. Increasing sulfotransferase is beneficial for metabolizing pro-drugs that require sulfonation to be activated, e.g., minoxidil sulfate is the active metabolite of minoxidil. A method for combining the compositions described herein with topical minoxidil to enhance minoxidil treatment for androgenetic alopecia is described. Additional methods and compositions include the use of retinoid X receptor agonists, retinoic acid receptor agonists, and nuclear receptor agonists in an RXR-NR heterodimer. Additional methods and compositions include the use of a topical solution containing an alkalinizing agent or an alkalinizing agent used with a penetration enhancer for up-regulating the sulfonating capacity of hair bearing skin, hair follicles, and/or keratinocyte cells. In addition, compositions and methods for increasing or decreasing the growth rate of hair follicles is disclosed by altering the intracellular pH. Additionally, methods for preparing a stable liposomal containing solution are described.
1 . A composition for increasing the sulfonating capacity of a hair follicle cell and/or keratinocyte cell, inducing sulfotransferase in a hair follicle, inducing expression of sulfotransferase, increasing sulfotransferase activity, upregulating sulfotransferase, converting non-responders to minoxidil responders, and/or improving minoxidil response, comprising:
an agent configured to induce expression of sulfotransferase in skin of a person, wherein said agent is an inorganic sulfur source chosen from the group consisting of cysteine, L-cysteine, hydrogen sulfide, elemental sulfur, sulfite, thiosulfate, polythionates, magnesium sulfate, sodium sulfate, and sodium metabisulfite;
a liposome solution comprising liposomes, said liposomes comprising lecithin or phosphatidylcholine, said liposomes encapsulating an alkalinizing agent, wherein said alkalinizing agent comprises TRIS; and
a buffer solution comprising sodium bicarbonate, acetate, citrate, Tris, or HEPES;
wherein the composition does not contain minoxidil or a salt thereof.
2 . The composition of claim 1 , wherein the composition is configured to be administered by applying the composition at a predetermined frequency and/or administering the composition prior to an application of topical minoxidil.
3 . The composition of claim 1 , wherein the composition is formulated as a cosmetic product.
4 . The composition of claim 1 , wherein the composition is formulated as any one or combination of a time release vehicle, a cream, a solution, a lotion, a serum, an ointment, a spray, an aerosol medium, a capsule, a shampoo, a gel, a foam, a cosmetic, a hair conditioner, a hair care product, a hair mask, a deodorant, an antiperspirant, a moisturizer, or a shaving cream or gel.
5 . The composition of claim 1 , wherein the inorganic sulfur source comprises sodium metabisulfite.
6 . The composition of claim 1 , wherein the liposome solution includes a buffering solution to stabilize the pH of the liposome solution.
7 . The composition of claim 1 , wherein the liposome solution includes an antioxidant to eliminate or slow oxidative degradation of the liposome solution.
8 . The composition of claim 7 , wherein the antioxidant includes ascorbic acid, monothioglycerol, potassium metabisulfite, sodium bisulfite, sodium formaldehyde sulfoxylate, sodium sulfite, sodium thiosulfate, tocopherol, sodium metabisulfite, butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), ascorbyl palmitate, propyl gallate, açai oil, alpha lipoic acid, green tea extract, retinal, vitamin C, coenzyme Q10 (Co Q-10), isoflavones, polyphenols, curcumin, turmeric, pomegranate, rosemary extract, glutathione, selenium, zinc, a chelating molecule, ethylenediaminetetraacetic acid (EDTA), disodium EDTA, tetrasodium EDTA, pentasodium penetate, sodium metasilicate and phosphate derivatives, etidronic acid and/or its derivatives, and/or galactaric acid.
9 . A kit for increasing the sulfonating capacity of a hair follicle cell and/or keratinocyte cell, inducing sulfotransferase in a hair follicle, inducing expression of sulfotransferase, increasing sulfotransferase activity, upregulating sulfotransferase, converting non-responders to minoxidil responders, and/or improving minoxidil response, the kit comprising a composition according to claim 1 and a dispenser, implant, or pill.
10 . The kit of claim 9 , wherein the composition is formulated as any one or combination of a time release vehicle, a cream, a solution, a lotion, a serum, an ointment, a spray, an aerosol medium, a capsule, a shampoo, a gel, a foam, a cosmetic, a hair conditioner, a hair care product, a hair mask, a deodorant, an antiperspirant, a moisturizer, or a shaving cream or gel.
11 . The kit of claim 9 , wherein the composition further includes minoxidil.
12 . The kit of claim 9 , wherein:
the liposome solution includes a buffering solution to stabilize the pH of the liposome solution; or
the liposome solution includes an antioxidant to eliminate or slow oxidative degradation of the liposome solution.
13 . The composition of claim 1 , further comprising a penetration enhancer.
14 . The composition of claim 1 , wherein:
the inorganic sulfur source is sodium metabisulfite;
the liposomes comprise phosphatidylcholine; and
the buffer solution comprises Tris.
15 . The composition of claim 14 , wherein the liposome solution includes an antioxidant to eliminate or slow oxidative degradation of the liposome solution.
16 . The composition of claim 15 , wherein the antioxidant comprises tocopherol.